No ordinary shares are being registered hereunder for sale by the company. The company will not receive any proceeds from the sale of the ordinary shares by the selling shareholders.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PLRZ:
- Polyrizon Achieves Milestone with Successful Safety Study of PL-14
- Polyrizon reports safety study results for PL-14 Allergy Blocker formulation
- Polyrizon Ltd. Shareholders Approve Key Amendments at Annual Meeting
- Polyrizon Faces Nasdaq Compliance Challenge
- Polyrizon Partners with Branding Firm for Strategic Brand Development